ArticleESMO open2026

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of cergutuzumab amunaleukin: a phase I study in patients with advanced and/or metastatic solid tumors.

U Lassen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.